Stocks · US
NTRA
XNAS
Natera, Inc. Common Stock
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B33.68x
P/S22.66x
EPS$-1.33
ROE-10.56%
ROA-7.24%
Dividend yield0.00%
Debt/Equity0.04
Free cash flow$84M
Returns and 52-week range
1W-3.35%
1M+22.08%
3M+46.01%
6M+91.45%
1Y+139.41%
YTD+75.08%
52W high$437.41
52W low$167.99
From 52W high-8.40%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 보스턴 사이언티픽 | $61.4B | 16.72 | 2.46 | -11.74% |
| Cencora, Inc. | $60.1B | 22.90 | 19.70 | -4.41% |
| The Cigna Group | $71.7B | 11.17 | 1.68 | -2.88% |
| Cardinal Health, Inc. | $54.0B | 31.49 | — | -5.56% |
| 리제네론 파머슈티컬스 | $74.8B | 17.28 | 2.36 | -10.75% |
| Edwards Lifesciences Corp | $50.3B | 50.03 | 4.74 | -3.80% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.